首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷

光學臨床前影像市場規模、佔有率和成長分析（按產品、應用和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1902597

光學臨床前影像市場規模、佔有率和成長分析（按產品、應用和地區分類）—2026-2033年產業預測

Optical Preclinical Imaging Market Size, Share, and Growth Analysis, By Product (Device, Consumables), By End Use (Pharma and Biotech Companies, Research Institutes), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球光學臨床前影像市場規模預計在 2024 年達到 50 億美元，從 2025 年的 50 億美元成長到 2033 年的 50 億美元，在預測期（2026-2033 年）內複合年成長率為 0%。

全球光學臨床前成像市場正經歷強勁成長，這主要得益於臨床前研究所需成像技術的進步。主要促進因素包括製藥和生物技術行業研發活動的活性化、對個人化醫療日益成長的關注，以及早期疾病檢測在臨床前研究中日益重要的地位。生物發光和螢光成像等非侵入性技術能夠高解析度地視覺化生物過程，顯著提升研究人員監測疾病進展和評估治療效果的能力。然而，成像系統的高成本以及動物實驗相關的倫理問題等挑戰可能會阻礙市場擴張。持續的技術創新、新型成像劑的湧現以及學術和研究機構的發展正在重塑光學臨床前成像的模式。

全球光學臨床前成像市場促進因素

全球光學臨床前影像市場的主要促進因素之一是生物醫學研發領域對先進成像技術日益成長的需求。各種疾病的盛行率不斷上升，以及對早期診斷和有效治療策略的需求不斷成長，正在推動創新影像解決方案的應用。光學臨床前成像能夠以高解析度即時可視化生物過程，使研究人員能夠更深入地了解疾病的潛在機制。此外，新型成像劑和更先進的成像系統等技術進步，透過提高臨床前研究的效率和準確性，進一步推動了市場成長。

限制全球光學臨床前影像市場的因素

全球光學臨床前成像市場的主要限制因素之一是成像系統及相關技術的高成本。這些先進的成像方式通常需要大量的資本投入，以及持續的維護和營運費用。這種經濟壁壘會限制中小型研究機構和實驗室的准入，對其採用和實施尖端成像技術的能力造成不成比例的影響。此外，嚴格的監管核准以及將這些系統整合到現有研究框架中的複雜性也會阻礙市場成長，並抑制相關人員投資於用於臨床前應用的新型光學成像解決方案的意願。

全球光學臨床前成像市場趨勢

全球光學臨床前成像市場正呈現顯著的多模態成像趨勢。研究人員擴大整合各種光學成像模式，以收集全面數據並提高臨床前研究的準確性。這種方法有助於更深入地了解生物過程，進而改善研究成果。此外，螢光探針和生物發光標記等先進成像標記技術的進步，使得細胞機制的可視化更加特異性和靶向。隨著研究人員和製藥公司對精準、多功能成像解決方案的需求不斷成長，這種向先進成像技術的轉變正在推動市場成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Bruker Corporation（USA）
MR Solutions（UK）
BioTek Instruments, Inc.（USA）
MILabs BV（Netherlands）
Magnetic Insight, Inc.（USA）
MBF Bioscience（USA）
FUJIFILM Corporation（Japan）
Mediso Ltd.（Hungary）
LI-COR Biosciences, Inc.（USA）
Siemens Healthineers（Germany）
General Electric（GE）Healthcare（USA）
Thorlabs, Inc.（USA）
Carl Zeiss AG（Germany）
Olympus Corporation（Japan）
Hamamatsu Photonics KK（Japan）
Berthold Technologies GmbH & Co.KG（Germany）
Endress+Hauser（Analytik Jena US LLC）（Germany/USA）
TriFoil Imaging（USA）
Vieworks Co., Ltd.（South Korea）

結論與建議

簡介目錄

Product Code: SQMIG35A2798

Global Optical Preclinical Imaging Market size was valued at USD 5 Billion in 2024 and is poised to grow from USD 5 Billion in 2025 to USD 5 Billion by 2033, growing at a CAGR of 0% during the forecast period (2026-2033).

The Global Optical Preclinical Imaging market is experiencing robust growth, fueled by advancements in imaging technologies essential for preclinical studies. Key drivers include heightened research and development activities within the pharmaceutical and biotechnology industries, a rising focus on personalized medicine, and an increased emphasis on early disease detection in preclinical research. Non-invasive techniques such as bioluminescence and fluorescence imaging enable high-resolution visualization of biological processes, significantly enhancing researchers' ability to monitor disease progression and evaluate treatment effectiveness. Nevertheless, challenges such as the high costs associated with imaging systems and ethical concerns regarding animal usage may impede market expansion. Continuous technological innovations, the emergence of novel imaging agents, and growth in academic and research institutions are reshaping the Optical Preclinical Imaging landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Optical Preclinical Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Optical Preclinical Imaging Market Segments Analysis

Global Optical Preclinical Imaging Market is segmented by Product, End Use and region. Based on Product, the market is segmented into Device, Consumables and Software. Based on End Use, the market is segmented into Pharma and Biotech Companies, Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Optical Preclinical Imaging Market

One of the key market drivers for the global optical preclinical imaging market is the increasing demand for advanced imaging technologies in biomedical research and drug development. The rising prevalence of various diseases, coupled with the need for early diagnosis and effective treatment strategies, propels the adoption of innovative imaging solutions. Optical preclinical imaging offers high-resolution, real-time visualization of biological processes, enabling researchers to understand the underlying mechanisms of diseases better. Additionally, technological advancements, such as the development of novel imaging agents and enhanced imaging systems, further stimulate market growth by improving the efficacy and accuracy of preclinical studies.

Restraints in the Global Optical Preclinical Imaging Market

One key market restraint for the global optical preclinical imaging market is the high cost of imaging systems and associated technologies. These advanced imaging modalities often require significant capital investment, as well as ongoing maintenance and operational expenses. This financial barrier can limit access for small and medium-sized research institutions and laboratories, disproportionately affecting their ability to adopt and implement cutting-edge imaging techniques. Furthermore, stringent regulatory approvals and the complexity of integrating these systems into existing research frameworks can hinder market growth, leading to hesitation among stakeholders to invest in new optical imaging solutions for preclinical applications.

Market Trends of the Global Optical Preclinical Imaging Market

The Global Optical Preclinical Imaging market is witnessing a notable trend towards multimodal imaging, where researchers are increasingly integrating various optical modalities to gather comprehensive data and enhance the accuracy of preclinical studies. This approach allows for a more in-depth understanding of biological processes, leading to improved research outcomes. Additionally, advancements in advanced imaging markers, such as fluorescent probes and bioluminescent markers, are facilitating more specific and targeted visualization of cellular mechanisms. This shift towards sophisticated imaging techniques is driving growth in the market, as the demand for precise and multifaceted imaging solutions continues to escalate among researchers and pharmaceutical companies.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Optical Preclinical Imaging Market Size by Product & CAGR (2026-2033)

Market Overview
Device
- Fluorescence
- Bioluminescence
Consumables
- Fluorescence
- Green Fluorescent Proteins
- Red Fluorescent Proteins
- Infrared Dyes
- Others
- Bioluminescence
- Luciferins
- Proluciferins
- Coelenterazine
- Others
Software

Global Optical Preclinical Imaging Market Size by End Use & CAGR (2026-2033)

Market Overview
Pharma and Biotech Companies
Research Institutes
Others

Global Optical Preclinical Imaging Market Size & CAGR (2026-2033)

North America (Product, End Use)
- US
- Canada
Europe (Product, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Bruker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MR Solutions (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioTek Instruments, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MILabs B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Magnetic Insight, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MBF Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mediso Ltd. (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LI-COR Biosciences, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
General Electric (GE) Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thorlabs, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carl Zeiss AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamamatsu Photonics K.K. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berthold Technologies GmbH & Co.KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endress+Hauser (Analytik Jena US LLC) (Germany/USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TriFoil Imaging (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vieworks Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments